Files in This Item:
   
ThumbnailWHO-HTM-TB-2017.20-eng.pdf

View/Open

Title: WHO best-practice statement on the off-label use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis
Authors: World Health Organization
Issue Date: 2017
Publisher: World Health Organization
Place of publication: Geneva
Language: English
Description: 9 p.
Subject: Tuberculosis, Multidrug-Resistant
Antitubercular Agents
Diarylquinolines
Off-Label Use
Nitroimidazoles
Context: drug therapy
Gov't Doc #: WHO/HTM/TB/2017.20
URI: http://www.who.int/iris/handle/10665/258941
License: CC BY-NC-SA 3.0 IGO
License URL: https://creativecommons.org/licenses/by-nc-sa/3.0/igo
Appears in Collections:Technical Documents



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.